Uranium Spot Price Jan Update 2022 : E.V. Blind-spots how to make electricity 101
Electric-powered vehicles or devices are like derivates market. The underlying stock is electricity in various forms of production and for not-so-first-world countries, the best cheap, and easy way is to produce using nuclear power at least giving them without a single day of the blackout.
In order to actually be able to use electric power, we need to have electricity in the order of 234,000 terawatt-hours. For normal usage but now with all this hype about Electric vehicles where are the sources to produce these orders of energy on top of the normal usage?
Nuclear power rebounds and increases 2% in 2021, reversing only half of the decline in output that took place in 2020. Seven new reactors came online in the second half of 2020 and Q1 2021, more than offsetting the three reactors retired over the same period. Up to ten more new reactors could be connected to the grid worldwide by the end of 2021, including four in China. Despite the increase in operational capacity over the course of the year, global nuclear power in 2021 remains slightly below the 2019 level.
Across advanced economies, nuclear power increases slightly in 2021, with output remaining 6% below 2019 levels. Nonetheless, nuclear remains the largest single source of low-carbon generation in these economies.
Nuclear power in the United States is expected to decline further in 2021, with five reactors scheduled to be retired during the year, leaving output more than 4% below 2019 levels. The anticipated declines in the United States in 2021 offset increases in other advanced economies. In Japan, the progressive restart of reactors is likely to increase nuclear output by 6% in 2021, reversing only a small fraction of the 30 TWh decline in output in 2020. Across the European Union, the output is set to increase by more than 2% in 2021, due primarily to higher electricity demand in France and a new reactor in Slovakia, but this increase is insufficient to make up for the drop in 2020. In emerging markets and developing economies, nuclear power is set to increase by over 5% in 2021, with new reactors coming online in several countries, led by China and complemented by new reactors in India, United Arab Emirates, Pakistan, and Russia. The growth in 2021 pushes output from nuclear to 8% above 2019 levels, with emerging market and developing economies increasing their share of global nuclear output to almost one-third, up from 29% in 2019.
The Complete Ferengi Rules Of Acquisition
1. Once you have their money, never give it back
2. You can’t cheat an honest customer, but it never hurts to try
3. Never spend more for an acquisition than you have to
4. Sex and profit are the two things that never last long enough
5. If you can’t break a contract, bend it
6. Never let family stand in the way of opportunity
7. Always keep you ears open
8. Keep count of your change
9. Instinct plus opportunity equals profit
10. A dead customer can’t buy as much as a live one
11. Latinum isn’t the only thing that shines
Continue reading “The Complete Ferengi Rules Of Acquisition”
Marijuana Smoke vs. Tobacco: Which is More Dangerous? Math behind Legalizing the illegal [whatever…]
It’s widely assumed that smoking is smoking and that the risks of marijuana will therefore be equal to the risks of smoking tobacco, but this doesn’t appear to be the case. Additionally, cannabis vaporizers could reduce the risk of marijuana consumption even further.
Economics of making agriculture profitable but not LED, VERTICAL, INDOOR ELECTRICAL CURRENT FARMING
Smoking tobacco is widely recognized as the leading preventable cause of death in the world. Smokers die an average of 10 years younger than non-smokers, and conditions such as lung cancer, coronary heart disease, and chronic obstructive pulmonary disease are caused by smoking tobacco. Marijuana is also (usually) smoked, and so it seems natural to assume that the risks of smoking it would be equal to the risks of smoking tobacco. The marijuana smoke vs. tobacco smoke issue seems irrelevant because smoking in any form is bad. However, research appears to show that while marijuana smoking is still dangerous, it is less so than smoking tobacco. The biggest advantage marijuana has over tobacco, though, is that people who use it medicinally or recreationally (where allowed by law) don’t have to smoke it.
Could legal marijuana dollars be the boost the U.S. economy needs during a pandemic-triggered recession?
On April 22, NJ Cannabis Insider in collaboration with Advance 360 will host a live webinar with some of the country’s leading cannabis experts to discuss pressing issues facing the industry. Register here.
America’s driving down a long stretch of bad road, and it doesn’t look like the exit will be anytime soon.
At least 22,000 people have died from COVID-19 related complications in the U.S. since the onset of the pandemic, and, in the past three weeks, nearly 17 million have lost their jobs and filed for unemployment benefits. By comparison, nearly 3,000 died in the Sept. 11, 2001 attacks and about 13 million lost their jobs during the Great Depression.
Despite the havoc COVID-19 continues to wreak upon our lives, communities and the economy, some believe cannabis could provide an avenue for recovery.
Jobs, jobs, jobs
Jackie Cornell, chief of health and policy innovations at 1906, said legalizing adult-use cannabis would create thousands of jobs in the leaf-touching industry and through auxiliary services — “construction, security, materials, marketing, legal…the list of work created beyond the license holders themselves is sizable.”
“While an outbreak of this size and scale is a once in a lifetime event, COVID is highlighting the fragility of our collective safety net,” Cornell told NJ Cannabis Insider. “Unemployment is soaring, the strain on our healthcare system is unrelenting and we still have a long road ahead of us before we return to ‘business as usual.’”
Cornell posited that the end of marijuana prohibition could have as wide spread an impact on the economy as the end of alcohol prohibition did nearly 100 years ago when the country was recovering from the Great Depression. Scholars estimate alcohol other excise taxes brought in $1.35 billion in federal tax revenue in 1934, about half of the government’s total revenue.
“There is pent up demand for access to cannabis but there are also so many of New Jersey’s most vulnerable unsure of how they are going to survive this economic downturn,” Cornell said. “And unfortunately it doesn’t appear as though the federal relief in the CARES Act is being rolled out clearly and swiftly.”
A chance for legalization?
Proponents of legalization have been looking for an opportunity to make moves legislatively this year, but it’s clear it won’t be easy to do so.
Fruqan Mouzon, the former counsel for the state Senate Majority Office and an attorney who represents cannabis clients, said conversations about legislation prior to the ballot referendum are already happening.
“Legislation is definitely possible prior to November,” Mouzon said.
“The opportunity is there and hopefully there will be some more receptivity,” said Duane Morris attorney Paul Josephson, who represents GTI NJ, which recently opened a medical marijuana dispensary in Paterson. “But at the moment, it’s certainly difficult to get any elected official to focus their time and energy on cannabis. It’s hard to see how the Legislature could focus on that in the time at hand, but we are in emergency times and it’s possible that the constraints the state finds itself under could push the state to look for a revenue bump.”
Still, not everyone is convinced cannabis has a pathway forward before the November ballot.
Chris Melillo, senior vice president of retail operations for Curaleaf, said he doesn’t believe the Garden State is ready for adult-use as the industry still needs time to ramp up production efforts to ensure adequate supply to meet anticipated demand.
“Curaleaf is focused on providing high-quality medical cannabis to our current patients,” Melillo said. “However, if the state adopts adult-use, it has the potential to benefit veterans and other groups of people who might benefit from access to medical cannabis but who don’t want to apply for the medical program. Adult-use would see additional sales from those potential patients.”
The storm ahead
Melillo said it’s not possible to know all the twists and turns ahead but there are other known factors they can anticipate.
“We can’t predict the long-term impact COVID-19 will have on the cannabis industry,” he said. “We can say that Curaleaf is still hiring at our retail and cultivation locations. As the largest supplier of medical cannabis in the state of New Jersey, our current production has the capacity to fulfill all of our patients’ needs and can continue to scale as the N.J. medical program continues to grow. We can do this while implementing additional COVID-19 measures to protect employees and patients.”
For Josephson, the challenges ahead may be something of a crucible, burning away those companies that have overextended themselves.
“Those who have been good managers and good stewards of their cash will hopefully be able to weather the storm,” Josephson said. “Those who are at the edge are going to find this to be a very challenging time.”
Alan Brochstein, the author of the 420 Investor and founding partner of New Cannabis Ventures, told that MSOs Cresco Labs Inc (OTCQX: CRLBF), Curaleaf Holdings Inc (OTCQX: CURLF), Green Thumb Industries Inc (OTCQX: GTBIF) and Trulieve Cannabis Corp (OTCQX: TCNNF) are the safest bets for cannabis investors in the current environment.